Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain.
about
Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of AntiretroviralsSoluble and cell-associated insulin receptor dysfunction correlates with severity of HAND in HIV-infected womenPotential utility of resting-state magnetoencephalography as a biomarker of CNS abnormality in HIV disease.Neuroimaging of HIV-associated neurocognitive disorders (HAND)Value of multi-b value DWI in the assessment of early cerebral changes in asymptomatic HIV-positive adolescents.Pathogenesis of HIV in the central nervous systemCross-sectional study of unexplained white matter lesions in HIV positive individuals undergoing brain magnetic resonance imaging.Value of perfusion-weighted MR imaging in the assessment of early cerebral alterations in neurologically asymptomatic HIV-1-positive and HCV-positive patients.HIV-associated neurocognitive disorder.Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction?Neurovascular and Neurometabolic Couplings in Dynamic Calibrated fMRI: Transient Oxidative Neuroenergetics for Block-Design and Event-Related Paradigms.HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER StudyCerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infectionTransient hypercapnia reveals an underlying cerebrovascular pathology in a murine model for HIV-1 associated neuroinflammation: role of NO-cGMP signaling and normalization by inhibition of cyclic nucleotide phosphodiesterase-5Neurocognitive functioning in acute or early HIV infection.Abnormal MEG oscillatory activity during visual processing in the prefrontal cortices and frontal eye-fields of the aging HIV brain.Brain alterations within the first 100 days of HIV infection.Longitudinal diffusion tensor imaging and perfusion MRI investigation in a macaque model of neuro-AIDS: a preliminary study.Plasma cytokine levels are related to brain volumes in HIV-infected individuals.Test-retest stability of calibrated BOLD-fMRI in HIV- and HIV+ subjectsHIV and chronic methamphetamine dependence affect cerebral blood flow.Determinants of HIV-induced brain changes in three different periods of the early clinical course: A data mining analysisMultimodal neuroimaging evidence of alterations in cortical structure and function in HIV-infected older adults.HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment.Regional cortical thinning associated with detectable levels of HIV DNA.Effect of HAART on Brain Organization and Function in HIV-Negative SubjectsSubstance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection.Structural brain alterations can be detected early in HIV infectionNeurobehavioral Disturbances During Acute and Early HIV Infection.Abnormalities in resting-state functional connectivity in early human immunodeficiency virus infection.Monocyte/macrophages and their role in HIV neuropathogenesis.Cerebral white matter integrity during primary HIV infectionAlterations in brain metabolism during the first year of HIV infection.Hyperperfusion in progressive multifocal leukoencephalopathy is associated with disease progression and absence of immune reconstitution inflammatory syndromeFunctional brain abnormalities during finger-tapping in HIV-infected older adults: a magnetoencephalography studyQuantitative MRI Measures in SIV-Infected Macaque Brains.HIV clades B and C are associated with reduced brain volumetricsReal-world impact of neurocognitive deficits in acute and early HIV infection.Applications and limitations of inflammatory biomarkers for studies on neurocognitive impairment in HIV infection.Decreased MEG beta oscillations in HIV-infected older adults during the resting state.
P2860
Q28069383-2A7690BD-425D-4906-A301-8A4A1B9D6D7AQ28729739-06A35241-A04A-42AB-B2DC-751D99895F63Q30513406-9B57B9D2-814B-4E49-9AA3-0E82E1827371Q30854917-F64B52A4-1112-47C1-BC52-494624499900Q31136296-BC6A58D9-50C4-446A-B3B4-DA4D79A711F7Q33781978-E86E82CF-762D-4D20-BE2A-6404E5E4317AQ33820078-51D7B812-72B4-4881-9920-28B91CD3B778Q33889960-0BB87C0A-3EF7-4314-9D2F-EDE375763FB2Q33939729-E72CCA17-5786-48EE-BE6D-EF8D8540689AQ34113118-224ADB4D-AEA6-413E-B05D-5F36BCDD65B2Q34117072-6A41A44D-CD2C-48BD-8E8F-98A6B8CD9F28Q34370880-021A040A-1D1A-4930-9055-F72668305368Q34466521-A22570F4-B20B-402F-BC07-CB3D499991A9Q34483568-6B408C44-8508-4FCE-A663-D62068AD30B8Q34544921-739C0916-B023-4E76-A0BB-4F301313CE97Q34805196-73C98345-DBE9-4869-8187-35BA5B33C7E1Q34994446-161D87A2-5C6E-46CD-8F55-62D9820EF61BQ35129891-55058CCD-CE42-47C2-A20F-026DD7A0356DQ35572270-C41092CB-D02C-4272-A28C-58E1F19982C4Q35590277-76CA7DD2-33BC-4F60-952A-0C0A4BA0A4DEQ35651997-3810DCFF-C652-41D0-ACB1-45A2FE809CDFQ35790117-FAAB46BF-7F70-4E64-B778-EF65ABA5594CQ35819368-3C52FFDC-2C46-4CC0-A7C7-55CA491C3872Q36009246-58B12A39-2DC6-4C8C-93FD-D2C7E47150CAQ36142331-D078C6CD-540E-42E2-BD54-1E6E2855058CQ36326853-F1EDBFF2-C359-47E1-902F-DF424D88A6A5Q36597621-20A1F69B-5950-42B7-853E-BD2A2CD04C03Q36626743-B8EDD717-D64D-4822-B457-7CA6C8C56B8EQ36725430-9506C337-28A6-4D23-9537-CD4DACA9D021Q36752578-AD2CC47C-52C9-4346-8CF5-2AAB8F26CB4AQ36991666-A6A8A374-DF08-4BC3-A502-4D29BD14BCA9Q37028677-FA4A120A-C232-49BC-951E-805BCD560DA6Q37122230-AA91DF59-B7EF-4FFD-9865-22DA6E1873F3Q37256223-51F9FA08-393F-4F15-BD61-DA025184E144Q37257522-1DE390DB-5C23-4991-ABA6-0D5DA5550E13Q37305895-07595B37-9B0E-4682-AB99-84AE875AC69BQ37354426-B807E49B-571B-4700-93BA-E08BB0053AE2Q37397235-B0A0CA68-D99C-46CF-99AC-22EE0ED1F30AQ37467991-DD24EED1-3386-4719-8ACD-F84DE826AE8BQ37552824-3FF3DBBD-0383-4577-86E9-482508400218
P2860
Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain.
@en
Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain.
@nl
type
label
Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain.
@en
Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain.
@nl
prefLabel
Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain.
@en
Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain.
@nl
P2093
P2860
P921
P1433
P1476
Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain
@en
P2093
D D Richman
HNRC group
J E Perthen
O Leontiev
P2860
P304
P356
10.1212/WNL.0B013E3181B59A97
P407
P577
2009-09-01T00:00:00Z